Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized, Double-Blind, Placebo-Controlled, Multi-Center, Definitive Phase III Study of the Effects of Ferric Citrate on Serum Phosphate in Subjects With End Stage Renal Disease

NCT01503736 is registered in ClinicalTrials.gov with Panion & BF Biotech Inc. as lead sponsor.

NCT NCT01503736
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01503736 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized, Double-Blind, Placebo-Controlled, Multi-Center, Definitive Phase III Study of the Effects of Ferric Citrate on Serum Phosphate in Subjects With End Stage Renal Disease
Lead sponsor
Panion & BF Biotech Inc.
Phase
Phase 3
Overall status
Completed
Start date
June 30, 2010
Completion date
Not reported
Enrollment
183 (actual)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

end stage renal disease, esrd, hyperphosphatemia